SMTC Stock Cash Flow Statements

Semtech Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Semtech Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-07-27	2025-04-27	2025-01-26	2024-10-27	2024-07-28	2024-04-28	2024-01-28	2023-10-29	2022-10-30	2022-07-31	2022-05-01	2022-01-30	2021-05-02	2021-01-31	2020-10-25	2020-07-26	2020-04-26	2020-01-26	2019-10-27	2019-07-28	2019-04-28	2019-01-27	2018-10-28	2018-07-29	2018-04-29	2018-01-28	2017-10-29	2017-07-30	2017-04-30	2017-01-29	2016-10-30	2016-07-31	2016-05-01	2016-01-31	2015-10-25	2015-07-26	2015-04-26	2015-01-25	2014-10-26	2014-07-27	2014-04-27	2014-01-26	2013-10-27	2013-07-28	2013-04-28	2013-01-27	2012-10-28	2012-07-29	2012-04-29	2012-01-29	2011-10-30	2011-07-31	2011-05-01	2011-01-30	2010-10-31	2010-08-01	2010-05-02

cash flows from operating activities:
net income	-27,064,000	19,345,000	39,144,000	-7,586,000	-170,295,000	-23,159,000	-642,357,000	-38,252,000	22,743,000	51,596,000	38,048,000	34,791,000	23,498,000	15,631,000	18,482,000	16,122,000	9,632,000	-4,393,000	17,599,000	5,366,000	13,294,000	13,340,000	12,165,000	25,169,000	12,382,000	-1,297,000	13,338,000	12,564,000	11,821,000	8,019,000	30,776,000	8,979,000	6,887,000	1,247,000	10,705,000	-313,000	-142,000	-15,441,000	17,623,000	17,898,000	7,867,000	-210,808,000	12,453,000	19,112,000	14,777,000	13,118,000	16,590,000	10,022,000	2,209,000	12,388,000	26,979,000	27,138,000	22,582,000	26,003,000	16,105,000	19,662,000	10,802,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	10,314,000	10,190,000	10,288,000	10,140,000	12,567,000	10,504,000	8,864,000	22,539,000	7,323,000	7,330,000	7,668,000	8,206,000	7,420,000	7,660,000	7,926,000	7,740,000	8,541,000	9,311,000	9,727,000	9,719,000	10,824,000	12,307,000	12,792,000	12,087,000	12,453,000	13,205,000	12,701,000	11,792,000	11,301,000																					4,929,000	4,803,000	4,540,000	4,271,000	4,181,000	4,412,000	3,985,000	3,870,000
amortization of right-of-use assets	1,356,000	1,346,000	1,330,000	1,353,000	1,758,000	1,431,000	1,530,000	1,672,000	1,173,000	1,162,000	1,140,000	1,121,000	1,055,000
investment impairments and credit loss reserves			0	0	0	1,109,000	1,679,000	1,990,000	29,000	-429,000	24,000	407,000	246,000	1,319,000	335,000	1,485,000	3,630,000
goodwill impairment							473,800,000	2,266,000
accretion of deferred financing costs	1,271,000	1,254,000		2,056,000	2,379,000	2,379,000
write-off of deferred financing costs	364,000	152,000		0
loss on extinguishment of debt			0	0
interest rate swap termination	-743,000	14,000
deferred income taxes	2,437,000	2,411,000	-20,728,000	-10,000	-50,000	-884,000	-15,719,000	5,813,000	2,122,000	-1,486,000	1,747,000	-2,242,000	-29,000	-275,000	-912,000	-6,025,000	-184,000	-7,413,000	-1,436,000	3,027,000	226,000	2,515,000	-4,131,000	744,000	-15,614,000	9,724,000	5,128,000	-2,771,000	3,151,000	-13,474,000	6,164,000	5,234,000	4,261,000	-5,378,000	4,796,000	-40,000	-390,000	-6,492,000	3,376,000	3,142,000	1,000	37,801,000	-1,285,000	-6,627,000	98,000	-35,037,000	-161,000	7,727,000	-20,152,000	-7,232,000	-1,030,000	3,453,000	2,786,000	1,275,000	337,000
share-based compensation	17,297,000	6,835,000	17,259,000	18,405,000	17,138,000	15,234,000	11,829,000	6,538,000	3,085,000	13,250,000	10,893,000	10,492,000	11,839,000		13,538,000	13,186,000	9,379,000													9,630,000
loss on disposition of business operations and assets	16,000	26,000				64,000																	-79,000					-12,000	436,000
equity method income	62,000	-1,046,000
gain from sale of investments			0	0	0	-277,000
corporate-owned life insurance	734,000	655,000	689,000	1,052,000	975,000	695,000	1,949,000	-415,000	-808,000	878,000	-47,000	46,000
changes in assets and liabilities:
accounts receivable	12,325,000	-3,107,000	-20,206,000	10,559,000	912,000	-19,613,000	22,427,000	2,291,000	-9,434,000	-4,745,000	5,147,000	2,806,000	3,915,000	-11,733,000	-7,028,000	-2,221,000	12,476,000	-483,000	-2,801,000	7,816,000	12,764,000	4,597,000	-5,443,000	-12,809,000	-7,844,000	13,273,000	-5,236,000	-5,019,000	-4,471,000	8,591,000	-3,173,000	-7,775,000	-5,046,000	10,777,000	6,600,000	24,336,000	-16,359,000	9,022,000	-9,855,000	-6,746,000	4,611,000	7,813,000	6,449,000	-381,000	-11,054,000	3,644,000	4,433,000	-12,815,000	-264,000	9,970,000
inventories	-13,001,000	-6,627,000	-220,000	-7,415,000	-7,399,000	-3,632,000	15,677,000	19,537,000	-3,455,000	-727,000	712,000	-8,844,000	-6,425,000	-9,127,000	-819,000	-615,000	-3,923,000	-2,902,000	4,952,000	-1,580,000	-9,801,000	-2,310,000	-2,266,000	7,411,000	5,609,000	182,000	3,726,000	1,869,000	-11,292,000	-3,261,000	-72,000	38,000	1,336,000	7,568,000	9,029,000	-5,462,000	-873,000	-13,246,000	-5,860,000	854,000	4,962,000	11,944,000	5,953,000	-1,643,000	-4,016,000	-5,484,000	-2,193,000	1,947,000	1,479,000	116,000	2,086,000	923,000	-2,449,000	-4,562,000	-6,375,000	-3,545,000	466,000
other assets	-5,051,000	2,281,000	2,540,000	-3,108,000	-9,905,000	13,610,000	15,020,000	-2,024,000	1,334,000	-181,000	3,017,000	3,046,000	5,815,000	40,000	-11,311,000	-591,000	-3,207,000	5,078,000	4,287,000	-7,548,000	598,000	-1,964,000	-2,813,000	5,288,000	-1,098,000	-3,339,000	-1,519,000	-4,364,000	3,265,000
accounts payable	1,420,000	9,805,000	-4,229,000	-12,173,000	12,031,000	19,053,000	-10,578,000	3,962,000	-9,106,000	5,802,000	-126,000	1,180,000	1,513,000	3,408,000	5,977,000	-2,960,000	-2,860,000	11,195,000	-6,336,000	-617,000	-1,639,000	2,214,000	2,703,000	-577,000	3,203,000	1,377,000	2,449,000	-4,985,000	-4,147,000	-3,674,000	3,605,000	1,353,000	1,817,000	4,303,000	-15,283,000	-5,653,000	21,613,000	-8,983,000	2,450,000	-1,192,000	-1,352,000	1,219,000	-10,034,000	-4,787,000	2,308,000	-924,000	7,721,000	1,663,000	-4,007,000	-9,933,000	2,120,000	600,000	3,859,000	-6,644,000	3,327,000	3,869,000	5,434,000
accrued liabilities	4,004,000	-15,444,000	4,190,000	17,847,000	-12,400,000	-14,260,000	-9,390,000	-37,916,000	4,897,000	24,038,000	-16,808,000	2,013,000	-14,659,000	317,000	1,449,000	6,009,000	-5,466,000	491,000	-1,966,000	10,117,000	-28,174,000	676,000	3,876,000	438,000	-6,852,000	10,282,000	-1,267,000	5,995,000	-12,536,000	1,697,000	3,815,000	6,745,000	-1,675,000	2,686,000	-6,278,000	-1,258,000	-8,095,000	1,800,000	2,378,000	8,876,000	-10,557,000	9,968,000	-2,567,000	1,147,000	-11,287,000	2,758,000	6,823,000	-2,182,000	-17,809,000	1,612,000	3,240,000	-1,828,000	-29,041,000	-465,000	14,182,000	3,506,000	-3,789,000
other liabilities	-3,337,000	-266,000	-10,404,000	-1,590,000	-1,697,000	-2,293,000	1,347,000	871,000	-1,759,000	-1,061,000	-1,469,000	-2,123,000	-4,188,000	-3,054,000	-1,388,000	2,643,000	-1,859,000	5,807,000	-488,000	-324,000	-1,371,000	-561,000	3,173,000	-2,686,000	-751,000	-15,016,000	666,000	53,000	2,124,000	-1,600,000	2,035,000	11,000	3,761,000	-798,000	-203,000	-1,532,000	3,078,000	5,453,000	-783,000	1,263,000	788,000	-2,547,000	1,290,000	2,213,000	2,392,000	1,320,000	2,435,000	462,000	863,000	347,000	-788,000	119,000	316,000	741,000	1,557,000	-685,000	1,337,000
net cash from operating activities	44,395,000	27,824,000	33,496,000	29,575,000	-4,995,000	-89,000	13,919,000	-5,847,000	18,181,000	77,278,000	50,051,000	50,986,000	32,585,000	27,254,000	28,377,000	37,216,000	26,083,000	45,255,000	33,268,000	33,352,000	6,741,000	47,198,000	51,998,000	49,338,000	35,029,000	38,635,000	26,854,000	35,637,000	10,359,000	32,918,000	39,227,000	31,666,000	13,801,000	34,460,000	18,870,000	34,049,000	14,697,000	11,631,000	33,392,000	38,368,000	22,769,000	30,597,000	28,939,000	41,295,000	17,150,000	35,189,000	54,908,000
cash flows from investing activities:
proceeds from sales of property, plant and equipment			24,000	0			2,000	366,000				28,000	32,000	365,000	0			23,000	186,000	30,000	113,000	0	102,000	-17,000	27,000	9,000	174,000	0	6,000									18,000	0			0	0	49,000	8,000
purchase of property, plant and equipment	-2,884,000	-1,650,000	-2,633,000	-483,000	-3,411,000	-1,334,000	-1,712,000	-6,576,000	-7,060,000	-7,268,000	-8,315,000		-5,760,000	-10,926,000	-7,168,000	-6,968,000	-7,672,000	-2,647,000	-3,516,000	-1,635,000	-15,258,000	-4,124,000	-3,107,000	-4,886,000	-4,935,000	-8,643,000	-7,866,000	-13,777,000	-5,175,000	-19,166,000	-8,406,000	-2,635,000	-2,713,000	-2,321,000	-2,461,000	-3,403,000	-4,841,000	-6,296,000	-12,797,000	-6,283,000	-6,379,000	-6,411,000	-7,185,000	-12,815,000	-10,750,000	-5,151,000	-7,400,000
proceeds from sale of investments	0	536,000	0	0	0	2,650,000			0					51,000	0							4,366,000	0	0	1,601,000
purchase of investments			0	0			0	0	-3,460,000	-1,288,000	-2,000,000		-2,927,000	0	-4,250,000	-2,800,000	-3,888,000	-2,038,000	-1,900,000	-7,067,000	-625,000	-2,596,000	-1,106,000	-105,000	-5,490,000	-5,328,000	-5,875,000	-2,712,000	-4,750,000
purchase of intangibles	-2,250,000	-529,000	-393,000	-930,000	-3,692,000	-1,326,000	-1,144,000	-479,000
proceeds from corporate-owned life insurance			0	0	3,001,000	1,801,000	6,423,000	0	2,389,000	0	2,676,000
premiums paid for corporate-owned life insurance	0	-3,428,000							-2,389,000	0	-2,676,000	0
net cash from investing activities	-5,131,000	-5,071,000	-7,802,000	-1,413,000	-4,463,000	1,791,000	3,569,000	-6,689,000	-10,977,000	20,531,000	-10,315,000	-10,485,000	-8,655,000	-10,510,000	-11,418,000	-9,421,000	-11,560,000	-4,662,000	-5,230,000	-8,672,000	-15,770,000	-11,037,000	-4,055,000	-12,329,000	-8,797,000	-13,962,000	-7,867,000	-34,108,000	-9,919,000	-29,113,000	22,194,000	-3,883,000	-2,713,000	-11,721,000	-13,961,000	858,000	-42,003,000	-14,180,000	-13,181,000	-4,809,000	-8,922,000	-9,111,000	-6,684,000	-11,502,000	-6,641,000	-8,507,000	-13,166,000			30,098,000	32,882,000	-39,199,000	-9,881,000	-60,495,000	-6,863,000	-4,537,000	-11,381,000
cash flows from financing activities:
payments of term loans	-25,000,000	-10,000,000					0	-261,188,000										-101,250,000	-4,687,000	-4,687,000	-4,688,000	-4,688,000	-3,750,000	-3,750,000	-3,750,000	-3,750,000	-3,750,000	-3,750,000	-3,750,000
proceeds from interest rate swap termination
deferred financing costs	-72,000	-492,000	0	0	0	-824,000	-7,549,000	-6,141,000						0	0	-6,000	-24,000
payments for employee share-based compensation payroll taxes	-3,290,000	-8,901,000	-6,728,000	-3,112,000	-1,760,000	-2,425,000	-1,238,000	-3,061,000
proceeds from exercise of stock options	468,000	32,000	3,087,000	605,000	408,000	235,000			0	203,000	417,000	990,000	628,000	3,409,000	2,109,000	2,093,000	888,000	1,556,000	1,492,000	1,573,000	1,381,000	5,826,000	2,401,000	4,010,000	4,038,000	1,340,000	3,008,000	1,173,000	1,159,000
distributions to noncontrolling interest			0	0	0	-184,000
net cash from financing activities	-27,657,000	-19,361,000	-9,603,000	-7,507,000	-1,352,000	-3,198,000	-13,787,000	-10,390,000	248,447,000	-10,843,000	-44,153,000	-37,499,000	-34,602,000	-10,124,000	-36,144,000	-15,286,000	-38,900,000	-30,326,000	-32,820,000	-24,143,000	-15,789,000	-36,277,000	-47,041,000	-29,024,000	-30,806,000	-7,875,000	-5,716,000	-5,225,000	-16,024,000	-4,610,000	-2,369,000	-4,925,000	-6,869,000	-3,288,000	-25,152,000	-33,809,000	8,482,000	391,000	-26,392,000	-36,046,000	-15,887,000	-15,685,000	-21,922,000	-23,161,000	-3,273,000	-8,444,000	-2,777,000	-4,934,000	341,304,000	-12,478,000	-23,311,000	10,938,000	19,126,000	8,110,000	13,575,000	1,260,000	4,950,000
effect of foreign exchange rate changes on cash and cash equivalents	479,000	1,339,000	-852,000	-79,000	-39,000	-312,000	1,064,000	-1,166,000
net increase in cash and cash equivalents	12,086,000	4,731,000	15,239,000				4,765,000	-24,092,000	255,651,000			3,002,000						10,267,000	-4,782,000			-116,000	902,000			16,798,000	13,271,000	-3,696,000	-15,584,000	-805,000	59,052,000	22,858,000	4,219,000					-2,158,000	-6,181,000	-2,487,000	-2,040,000	5,801,000	333,000	6,632,000	7,236,000	18,238,000	39,096,000	26,957,000	-88,121,000	43,882,000	42,551,000	5,984,000	15,586,000	-23,190,000	36,291,000	23,551,000	1,769,000
cash and cash equivalents at beginning of period	0	151,743,000	0	0	0	128,585,000	0	0	0	0	279,601,000	0	268,891,000	0	0	0	293,324,000	0	0	0	312,120,000	0	0	0	307,923,000	0	0	0	297,134,000	0	0	0	211,810,000	0	0	0	230,328,000	0	0	0	243,194,000	0	0	0	223,192,000	0	0	0	227,022,000	0	0	0	119,019,000	0	0	0	80,598,000
cash and cash equivalents at end of period	12,086,000	156,474,000	15,239,000	20,576,000	-10,849,000	126,777,000	4,765,000	-24,092,000	255,651,000	86,966,000	275,184,000	3,002,000	258,219,000	6,620,000	-19,185,000	12,509,000	268,947,000	10,267,000	-4,782,000	537,000	287,302,000	-116,000	902,000	7,985,000	303,349,000	16,798,000	13,271,000	-3,696,000	281,550,000	-805,000	59,052,000	22,858,000	216,029,000	19,451,000	-20,243,000	1,098,000	211,504,000	-2,158,000	-6,181,000	-2,487,000	241,154,000	5,801,000	333,000	6,632,000	230,428,000	18,238,000	39,096,000	26,957,000	138,901,000	43,882,000	42,551,000	5,984,000	134,605,000	-23,190,000	36,291,000	23,551,000	82,367,000
supplemental disclosure of cash flow information:
interest paid		3,526,000			25,205,000	17,147,000			8,336,000	944,000	987,000		1,065,000		2,312,000	1,094,000	1,570,000		2,293,000	2,136,000	2,212,000		1,805,000	1,971,000	1,929,000	1,144,000	1,707,000	1,681,000	1,809,000
income taxes paid		1,335,000			1,040,000	2,769,000			3,374,000	2,028,000	3,347,000		2,917,000		3,454,000	766,000	3,866,000		951,000	5,850,000	1,730,000		1,103,000	2,291,000	648,000	6,381,000	21,554,000	1,209,000	1,869,000
non-cash investing and financing activities:
accounts payable related to capital expenditures		247,000			-62,000	331,000			419,000	-424,000	3,808,000		2,355,000		2,042,000	-1,058,000	2,435,000
accrued deferred financing costs		72,000
accrued purchases of intangibles		5,130,000
right-of-use asset impairment
intangible impairment
accretion of deferred financing costs and debt discount									279,000	120,000	121,000	120,000	121,000	120,000	120,000	121,000	121,000	119,000	118,000	122,000	125,000	129,000	130,000	133,000	136,000	138,000	141,000	143,000	146,000	129,000	160,000	164,000	168,000	415,000	394,000	347,000	313,000	294,000	278,000	261,000	250,000	254,000	245,000	250,000	760,000	726,000	738,000	753,000	328,000
write-off of deferred financing costs and debt discount																																										0	-1,680,000
gain on disposition of business operations and assets			138,000	33,000			267,000	-242,000																		-7,000
equity method loss								11,000
amortization of inventory step-up							0	0
proceeds from sale of business, net of cash disposed									-490,000
acquisition, net of cash acquired																							56,000
proceeds from revolving line of credit							0	10,000,000	0	0	10,000,000	0
payments of revolving line of credit			-278,250,000						-23,000,000			-4,000,000	-4,000,000	-4,000,000	-4,000,000	-4,000,000	-4,000,000
proceeds from term loans
proceeds from convertible senior notes							0
proceeds from sale of warrants
purchase of convertible note hedge
proceeds from issuance of common stock, net of issuance costs
repurchase of common stock									0	0	-50,000,000	-32,746,000	-25,000,000	-5,000,000	-24,046,000	-12,387,000	-30,000,000	-27,583,000
accrued purchase of intangibles
debt extinguished in exchange for common stock
conversion of notes into equity													626,000
equity method (income) loss				12,000	0	-50,000
net decrease in cash and cash equivalents					-10,849,000	-1,808,000					-4,417,000		-10,672,000		-19,185,000	12,509,000	-24,377,000				-24,818,000				-4,574,000										-20,243,000	1,098,000	-18,824,000
changes in the fair value of contingent earn-out obligations														0	0	0	-33,000	-32,000
payments of earn-out																		0
equity in net gains of equity method investments									36,000	-283,000	-24,000	0
payment for employee share-based compensation payroll taxes									-8,150,000	-1,046,000	-4,570,000		-6,230,000	-4,533,000	-10,207,000	-986,000	-5,764,000	-993,000	-7,113,000	-1,029,000	-12,372,000	-737,000	-7,162,000	-4,871,000	-5,769,000	-1,010,000	-4,974,000	-2,220,000	-3,467,000	-634,000
(gain) loss on disposition of business operations and assets																									-10,000
gain on disposition of assets											8,000		-20,000								-106,000
(gain) loss on disposition of assets															0
income taxes payable																		0	0	0	-2,105,000	2,105,000	0	1,000	-1,698,000	1,802,000	-18,848,000	4,550,000	-3,222,000																											7,063,000	-7,907,000
purchases of property, plant and equipment																																																	-4,630,000	-3,557,000	-2,748,000	-7,790,000	-7,469,000	-7,521,000	-7,674,000	-5,856,000	-4,486,000
purchases of investments
contributions from noncontrolling interest																		0
equity in net (gains) losses of equity method investments													-78,000					0
corporate owned life insurance													2,562,000	2,311,000	2,167,000	2,205,000	-175,000	2,255,000	2,602,000	-269,000	1,025,000	-75,000	-604,000	899,000	-254,000	758,000	289,000	306,000	248,000
share-based compensation and warrant costs																		23,308,000	8,767,000	8,646,000	11,328,000	12,912,000	11,466,000	13,965,000	35,516,000	3,770,000	15,356,000	15,524,000	13,286,000
gain from sale of investment
acquisitions, net of cash acquired																																		5,261,000	-9,500,000	0	-34,932,000									0	0	0	-491,717,000
equity in net incomees of equity method investments																137,000	11,000			-168,000	411,000	85,000	-17,000	27,000	31,000	50,000
supplemental disclosure of cash flow information
impairment of investments																						0
gain from convertible debt settlement																										0
proceeds from convertible debt settlement																										0
deferred revenue																			-1,119,000	-1,487,000	1,503,000	2,474,000	-435,000	127,000	-180,000	29,000	-251,000	-103,000	299,000	1,233,000	2,118,000	1,049,000	133,000	1,747,000	-9,000	-3,000	1,045,000	-2,011,000	1,432,000	733,000	-1,573,000	-273,000	2,142,000	281,000	1,251,000	-881,000	-1,545,000	576,000	738,000	-770,000	-1,079,000	790,000	-108,000	-190,000	1,274,000	483,000	177,000
decrease in accounts payable related to capital expenditures
loss on disposition of assets
earn-out liabilities																				0	-2,161,000	0	-8,519,000			3,704,000				-53,000	0	-129,000	-33,000	-2,744,000	-14,186,000
repurchase of outstanding common stock																				-20,000,000	-110,000	-36,472,000	-30,000,000	-24,413,000	-25,325,000	-4,455,000	0	-428,000	-9,966,000	-466,000	0			0	-7,464,000	-29,833,000	-20,014,000	0	-20,906,000	-10,000,000	-10,000,000	-15,000,000				-7,500,000	0	-87,000	-182,000	-20,086,000	-30,028,000	-101,000	-450,000	-105,000	-1,312,000	-1,026,000	-376,000
non-cash items
capital expenditures in accounts payable																				831,000	1,193,000		-136,000	260,000	2,054,000
contingencies																												95,000	-50,000
proceeds from disposition of business operations																														-45,000
payment of earn-out																						-206,000
convertible debt																												-1,000,000	2,175,000
impairment of assets																										0
capital expenditures																												391,000	1,511,000
free cash flows																												36,028,000	11,870,000
intangible asset impairments
effect of acquisition fair value adjustments																																										0	0	53,000	2,476,000	4,442,000	4,651,000
excess tax benefits on share-based compensation
proceeds from sales and maturities of available-for-sale investments																																						550,000	0	2,624,000	500,000	750,000	501,000	1,000,000	7,998,000	7,767,000	1,500,000	14,607,000	88,592,000	36,626,000	45,118,000	27,421,000	22,583,000	31,026,000	31,693,000	23,433,000	24,835,000
purchase of intangible assets																																						-100,000	0			-950,000	0	264,000	-2,847,000	-1,001,000				0
depreciation, amortization and impairments																															11,619,000	11,961,000	11,926,000	12,398,000	12,514,000	11,980,000	12,040,000	33,056,000	12,217,000	12,026,000	12,004,000	51,687,000	13,449,000	15,591,000	13,346,000
environmental reserve																															-2,000			0	0
prepaid expenses and other assets																															858,000	143,000	-12,786,000	-5,356,000	4,987,000	5,672,000	-4,684,000	-4,098,000	2,443,000	-3,012,000	-1,235,000	3,631,000	-3,054,000	1,230,000	-1,184,000	91,000	-421,000	2,189,000	4,112,000	1,047,000	-706,000	-6,227,000	-1,182,000	2,511,000	5,711,000	-6,375,000	-2,387,000
income taxes payable and prepaid taxes																															-3,016,000	-2,204,000	-2,655,000	525,000	688,000	193,000	1,205,000	4,572,000	-256,000	-1,993,000	154,000	4,463,000	-1,249,000	-47,000	-1,342,000	26,574,000	-2,937,000	-20,356,000	-4,401,000	5,843,000	-1,222,000	1,661,000	-1,320,000
purchases of other investments																															-2,000,000				-2,000,000	-1,000,000	-2,230,000
proceeds from sale of equity investments																																			0
borrowings under line of credit																																			0	0	35,000,000
proceeds from exercises of stock options																															710,000	754,000	214,000	1,842,000	997,000	1,183,000	1,785,000	928,000	1,977,000	4,190,000	1,785,000	-217,000	-2,235,000	5,976,000	2,352,000
payment of long term debt																															0	-4,687,000	-4,687,000	-4,687,000	-16,688,000	-4,688,000	-4,687,000	-4,687,000	-4,687,000	-29,688,000	-4,687,000	-4,688,000	-4,688,000	-353,500,000	-5,625,000	-5,625,000	-5,625,000
stock-based compensation																																6,097,000	5,707,000	7,070,000	5,116,000	2,336,000	5,946,000	8,573,000	7,935,000	6,274,000	6,847,000	2,979,000	6,828,000	6,156,000	8,626,000	7,801,000	6,482,000	4,919,000	5,326,000	6,871,000	5,041,000	4,621,000	7,487,000	6,085,000	7,419,000	7,206,000	8,300,000
loss on disposition of property, plant and equipment																																																45,000	40,000			0	7,000		6,000	-12,000	75,000
payment for employee stock-based compensation payroll taxes																																-453,000	-2,396,000		-1,997,000	-471,000	-3,602,000		-2,776,000	-548,000	-2,985,000
adjustments to reconcile net income to net cash from operating activities, net of effects of acquisitions:
impairment - goodwill
excess tax benefits on stock based compensation																																															-422,000	-1,071,000	-1,842,000	48,000	-608,000	-644,000	-1,075,000		-48,000	24,000	-257,000
gain on disposition of property, plant and equipment																																								-16,000	2,000
purchases of available-for-sale investments																																										0	0	0	-1,050,000	-7,622,000	-7,016,000
purchase of cost method investment																																						-3,500,000	-384,000	-221,000	-3,043,000
proceeds from debt issuance, net of discount																																										0	896,000			0	0
deferred financing cost																																										0	-895,000			0	0	0	-8,962,000
payments for employee stock-based compensation payroll taxes
effect of exchange rate increase on cash and cash equivalents																																														0	131,000	-236,000	170,000
payment for interest rate cap																																														0	0
write off deferred financing costs & debt discount
proceeds of debt issue, net of discount																																																	347,000,000
(gain) loss on disposition of property, plant and equipment																																										0	-1,000	-26,000	-1,000
payment on interest rate cap
depreciation, amortization and impairment																																															12,755,000	1,249,000	21,296,000
accrued interest expense																																															-41,000	-123,000	350,000
proceeds from issuance of common stock																																															2,426,000				6,109,000
adjustments to reconcile net income to net cash from operations, net of effects of acquisitions:
net cash from operations																																																	-11,734,000	26,264,000	32,982,000	34,245,000	6,341,000	29,195,000	29,578,000	26,828,000	8,200,000
purchase of available-for-sale investments																																																	-10,106,000	-2,999,000	-6,501,000	-58,830,000	-25,000,000	-84,000,000	-30,907,000	-22,163,000	-31,732,000
proceeds from sale of property, plant and equipment																																																		28,000	13,000	0	5,000	0	25,000	49,000	2,000
net cash (used in) investing activities																																																	-417,861,000
excess tax benefit received on stock options																																																	1,842,000
exercise of stock options																																																	1,606,000				18,501,000	7,605,000	14,839,000	2,310,000	5,069,000
adjustments to reconcile net income to net cash from operations:
impairment of acquired intangible assets																																																		0
repayment of debt
effect of foreign currency translation on cash and cash equivalents
receivables																																																				-901,000	208,000	8,301,000	-9,902,000	-9,165,000	-8,681,000
excess tax benefits
(gain) loss on disposition of property, plant and equipment and available for sale securities
insurance recovery
purchases of intangibles
effect of exchange rate changes on cash and cash equivalents
tax benefit on stock based compensation																																																									760,000

We provide you with 20 years of cash flow statements for Semtech stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Semtech stock. Explore the full financial landscape of Semtech stock with our expertly curated income statements.

The information provided in this report about Semtech stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.